A new tool is revealing the invisible networks inside cancer

2025-12-21 · Source: Robotics Research News -- ScienceDaily · Field: Technology & Digital — Artificial Intelligence & Machine Learning, Data Science & Analytics, Software Development & Engineering · Depth: Advanced, short

Summary

Spanish researchers from the University of Navarra have developed RNACOREX, a new open-source software platform designed to uncover hidden gene regulation networks in cancer. Published in *PLOS Computational Biology*, RNACOREX analyzes thousands of molecular interactions, specifically microRNAs (miRNAs) and messenger RNA (mRNA), to reveal how genes communicate within tumors and their relationship to patient survival. Tested across 13 different cancer types using data from The Cancer Genome Atlas (TCGA), the tool matches the predictive accuracy of advanced AI systems while providing clear, interpretable explanations of molecular relationships. RNACOREX helps identify regulatory networks linked to clinical outcomes, detect shared molecular patterns across tumor types, and pinpoint individual molecules with biomedical relevance, offering a reliable "molecular map" to prioritize new biological targets.

Key takeaway

For AI scientists and oncologists seeking to understand cancer progression, RNACOREX offers a transparent alternative to "black-box" AI models. You can use this open-source tool to generate new hypotheses about tumor growth and identify promising diagnostic markers or treatment targets, accelerating personalized cancer medicine. Integrate RNACOREX into your research workflows to gain interpretable insights into complex molecular interactions.

Key insights

RNACOREX reveals hidden gene networks in cancer, predicting survival with AI-level accuracy and interpretable molecular explanations.

Principles

• Interpretable models enhance scientific understanding.
• Molecular network architecture drives tumor behavior.
• Open-source tools accelerate biomedical research.

Method

RNACOREX integrates curated biological databases with gene expression data to rank miRNA-mRNA interactions, building complex regulatory networks that function as probabilistic models for disease behavior.

In practice

• Identify regulatory networks linked to clinical outcomes.
• Detect molecular patterns across tumor types.
• Prioritize new biological targets for cancer research.

Topics

• RNACOREX
• Cancer Genomics
• Gene Regulation Networks
• Explainable AI
• Survival Prediction

Code references

• digital-medicine-research-group-UNAV/RNACOREX

Best for: AI Scientist, AI Researcher, Research Scientist, AI Data Scientist

Related on AIssential

• Seesaw signatures capture trajectory-like transcriptomic shifts and enable compact tumour cell classification across cancers — Seesaw pairs offer a compact, interpretable method for accurate tumor cell classification via gene expression rank reversals.
• Zuckerberg's $500M AI biology swing — Large-scale data generation and advanced AI models are converging to revolutionize disease understanding and food science.
• Discovery of candidate therapeutic targets with Geneformer — Geneformer leverages a transformer model and transfer learning for gene network analysis and therapeutic target discovery with limited data.
• 3 Questions: Building predictive models to characterize tumor progression — AI and ML tools can decode tumor evolution, especially ecDNA amplifications, to predict and counter treatment resistance.
• Learning Directional Semantic Transitions for Longitudinal Chest X-ray Analysis — ProTrans models disease progression in CXRs as directional semantic transitions using vision-language pretraining and radiology reports.
• “Curing All Disease by next century is too conservative" - Mark Zuckerberg — Integrating frontier AI with frontier biology and open-source tools accelerates disease understanding and personalized therapeutic design.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Robotics Research News -- ScienceDaily.